Abstract:Dysregulation of the Hippo pathway occurs in a variety of cancers and often correlates with a poor prognosis. To further explore the potential role of Hippo pathway dysregulation in tumor development and progression, we investigated its downstream transcription factor TEAD4 in colorectal cancer (CRC). Increased expression and nuclear localization of TEAD4 were found in a significant portion of CRC tissues, in association with metastasis and a poor prognosis. In CRC cells, TEAD4 knockdown induced the mesenchymal-epithelial transition and decreased cell mobility in vitro and metastasis in vivo. Microarray analysis revealed that TEAD4 promoted cell adhesion and upregulated the epithelial-mesenchymal transition-related transcriptome in CRC cells. Vimentin was identified as a new direct target gene mediating TEAD4 function in CRC cells, whereby forced vimentin expression markedly reversed TEAD4-knockdown-induced cell morphological changes and decreased mobility. Interestingly, rescued expression of both WT TEAD4 and a Y429H mutant can reverse the mesenchymal-epithelial transition and increase vimentin expression, cell mobility and metastatic potential in TEAD4-knockdown CRC cells. The discrepant expression of YAP and TEAD4 in CRC tissues, the rescue ability of TEAD4 mutant defect in YAP binding and no effect on vimentin expression by YAP knockdown in CRC cells, all implicated a YAP-independent manner of TEAD4 function in CRC. Furthermore, vimentin positively correlated and CDH1 reversely correlated with the level of TEAD4 in CRC tissues and xenograft tumors. Our results suggest that TEAD4 nuclear expression can serve as a biomarker for CRC progression and poor prognosis. The transcription factor TEAD4 regulates a pro-metastasis transcription program in a YAP-independent manner in CRC, thus providing a novel mechanism of TEAD4 transcriptional regulation and its oncogenic role in CRC, independently of the Hippo pathway.

The YAP–TEAD4 Complex Promotes Tumor Lymphangiogenesis by Transcriptionally Upregulating CCBE1 in Colorectal Cancer

TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1

TEAD Mediates YAP-dependent Gene Induction and Growth Control

Increased Tead4 Expression and Nuclear Localization in Colorectal Cancer Promote Epithelial-Mesenchymal Transition and Metastasis in A Yap-Independent Manner

CCBE1 Promotes Tumor Lymphangiogenesis and is Negatively Regulated by TGFβ Signaling in Colorectal Cancer.

Tead Transcription Factors Mediate the Function of Taz in Cell Growth and Epithelial-Mesenchymal Transition

VGLL4 Targets a TCF4–TEAD4 Complex to Coregulate Wnt and Hippo Signalling in Colorectal Cancer

CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

ETV4 Potentiates Nuclear YAP Retention and Activities to Enhance the Progression of Hepatocellular Carcinoma.

PRDM 4 Mediates YAP ‐induced Cell Invasion by Activating Leukocyte‐specific Integrin Β2 Expression

Both Tead-Binding and Ww Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein

Data from Endothelin Promotes Colorectal Tumorigenesis by Activating YAP/TAZ

Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

SNHG16 upregulation-induced positive feedback loop with YAP1/TEAD1 complex in Colorectal Cancer cell lines facilitates liver metastasis of colorectal cancer by modulating CTCs epithelial-mesenchymal transition

Structural Basis of YAP Recognition by TEAD4 in the Hippo Pathway.

Knockdown of TAZ Modifies Triple-Negative Breast Cancer Cell Sensitivity to EGFR Inhibitors by Regulating YAP Expression.

YAP/TAZ: a promising target for squamous cell carcinoma treatment

YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma